» Articles » PMID: 22750012

Study of Possible Combined Toxic Effects of Azaspiracid-1 and Okadaic Acid in Mice Via the Oral Route

Overview
Journal Toxicon
Specialty Toxicology
Date 2012 Jul 4
PMID 22750012
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Toxins from the okadaic acid (OA) and azaspiracid (AZA) group cause considerable negative health effects in consumers when present in shellfish above certain levels. The main symptoms, dominated by diarrhoea, are caused by damage to the gastrointestinal (GI) tract. Even though OA and AZAs exert toxicity via different mechanisms, it is important to find out whether they may enhance the health effects if present together since they act on the same organs and are regulated individually. In this study, the main issue was the possibility of enhanced lethality in mice upon combined oral exposure to OA and AZA1. In addition, pathological effects in several organs and effects on absorption from the GI tract were studied. Although the number of mice was small due to low availability of AZA1, the results indicate no additive or synergistic effect on lethality when AZA1 and OA were given together. Similar lack of increased toxicity was observed concerning pathological effects that were restricted to the GI-tract. OA and AZA1 were absorbed from the GI-tract to a very low degree, and when given together, uptake was reduced. Taken together, these results indicate that the present practice of regulating toxins from the OA and AZA group individually does not present an unwanted increased risk for consumers of shellfish.

Citing Articles

Effects of okadaic acid, azaspiracid-1, yessotoxin and their binary mixtures on human intestinal Caco-2 cells.

Alarcan J, Braeuning A EXCLI J. 2024; 23:509-522.

PMID: 38741723 PMC: 11089091. DOI: 10.17179/excli2023-6884.


The health risks of marine biotoxins associated with high seafood consumption: Looking beyond the single dose, single outcome paradigm with a view towards addressing the needs of coastal Indigenous populations in British Columbia.

Lee M, Henderson S, Clermont H, Turna N, McIntyre L Heliyon. 2024; 10(5):e27146.

PMID: 38463841 PMC: 10923677. DOI: 10.1016/j.heliyon.2024.e27146.


Current Research Status of Azaspiracids.

Yang J, Sun W, Sun M, Cui Y, Wang L Mar Drugs. 2024; 22(2).

PMID: 38393050 PMC: 10890026. DOI: 10.3390/md22020079.


Okadaic Acid Is at Least as Toxic as Dinophysistoxin-1 after Repeated Administration to Mice by Gavage.

Park S, Kang J, Jung H, Hwang J, Chun H, Yoon Y Toxins (Basel). 2023; 15(10).

PMID: 37888618 PMC: 10611360. DOI: 10.3390/toxins15100587.


Acute Toxicity by Oral Co-Exposure to Palytoxin and Okadaic Acid in Mice.

Sosa S, Pelin M, Ponti C, Carlin M, Tubaro A Mar Drugs. 2022; 20(12).

PMID: 36547882 PMC: 9781071. DOI: 10.3390/md20120735.